Why does eliminating antigen retrieval matter for target validation?

Eliminating antigen retrieval preserves epitope integrity and reduces procedural variability, leading to more reliable protein detection in target validation studies. This simplification decreases hands-on time and minimizes artifacts that could confound mechanistic interpretation. The approach supports consistent immunostaining results critical for de-risking therapeutic hypotheses.

How does cryosectioning of undecalcified hard tissues fit the discovery pipeline?

Cryosectioning of undecalcified tissues enables direct protein analysis without decalcification, maintaining native antigen presentation in hard tissues like bone and cartilage. This capability fits early discovery by allowing spatial protein expression studies in disease-relevant craniofacial models. It supports target validation by providing access to tissues that would otherwise require harsh treatment compromising antigenicity.

What quantitative dependent variable measurements enable mechanistic de-risking?

Fluorescence intensity measurements from immunostained sections enable quantification of protein expression levels across experimental groups. These quantitative readouts allow researchers to assess changes in biomarkers such as pSmad1/5/9 or Ki67 in response to genetic or pharmacological perturbations. Such data supports mechanistic de-risking by providing objective metrics for target engagement and pathway modulation.

Why do replication requirements matter for cross-functional collaboration?

Replication requirements ensure that immunostaining results are reproducible across different operators, sessions, and laboratories, which is essential for cross-functional team confidence. Standardized cryosectioning and staining protocols minimize variability, enabling reliable data sharing between discovery, screening, and preclinical teams. This consistency supports unified interpretation of protein expression data in target validation and assay development efforts.

What statistical analysis capabilities are required before implementation?

Implementation requires capability to perform quantitative fluorescence analysis and statistical comparison of protein expression levels between control and experimental groups. Researchers need to define appropriate thresholds for significant changes in markers like SOX9 or Osterix to inform go/no-go decisions. Basic statistical tools for comparing mean fluorescence intensity and assessing variability are necessary to derive actionable insights from the immunostaining data.

Fare Kraniyofacial dokularda ve Undecalcified kemik doku hazırlama ve Immünostasyon

12.8K görüntüleme

8 kez atıf

10:03 dk

10 Mayıs 2019

10.3791/59113-v

10 Mayıs 2019

12.8K görüntüleme

Jingwen Yang^*¹^,² , Haichun Pan^*² , Yuji Mishina²

¹The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory for Oral Biomedicine of Ministry of Education, School and Hospital of Stomatology, Wuhan University, ²Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan

^* These authors contributed equally

Burada, kraniyofasiyal morphogenesis/patogenezi sırasında protein düzeylerini algılamak ve ölçmek için ayrıntılı bir protokol sunuyoruz Buna ek olarak, immünostasyon için genç farelerden undecalcified Sert dokularda hazırlama ve donuk kesit için bir yöntem açıklanmaktadır.